Pharming Group NV banner

Pharming Group NV
OTC:PHGUF

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
OTC:PHGUF
Watchlist
Price: 1.28 USD Market Closed
Market Cap: $868.3m

Wall St Price Targets

PHGUF Price Targets Summary
Pharming Group NV

Wall Street analysts forecast PHGUF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHGUF is 2.73 USD with a low forecast of 2.2 USD and a high forecast of 3.31 USD.

Lowest Forecast
Price Target
2.2 USD
72% Upside
Average Forecast
Price Target
2.73 USD
114% Upside
Highest Forecast
Price Target
3.31 USD
158% Upside
Pharming Group NV Competitors:
Price Targets
NSIT
Insight Enterprises Inc
-13% Downside

Revenue
Forecast

41% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
41% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.

Operating Income
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 36%.

Net Income
Forecast

N/A
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
N/A
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

The compound annual growth rate for Net Income over the next 4 years is 130%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PHGUF's stock price target?
Price Target
2.73 USD

According to Wall Street analysts, the average 1-year price target for PHGUF is 2.73 USD with a low forecast of 2.2 USD and a high forecast of 3.31 USD.

What is the Revenue forecast for Pharming Group NV?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.

What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
36%

The compound annual growth rate for Operating Income over the next 5 years is 36%.

What is the Net Income forecast for Pharming Group NV?
Projected CAGR
130%

The compound annual growth rate for Net Income over the next 4 years is 130%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett